Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1743-422X

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype ; volume:13 ; number:1 ; day:18 ; month:4 ; year:2016 ; pages:1-12 ; date:12.2016
Virology journal ; 13, Heft 1 (18.4.2016), 1-12, 12.2016

Creator: Bhardwaj, Suvercha

Contributor: Ahmad, Fareed
Wedemeyer, Heiner
Cornberg, Marcus
Schulze zur Wiesch, Julian
van Lunzen, Jan
Sarin, Shiv K.
Schmidt, Reinhold E.
Meyer-Olson, Dirk
SpringerLink (Online service)

DOI: 10.1186/s12985-016-0507-5

URN: urn:nbn:de:1111-201604202715

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:57 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Bhardwaj, Suvercha
Ahmad, Fareed
Wedemeyer, Heiner
Cornberg, Marcus
Schulze zur Wiesch, Julian
van Lunzen, Jan
Sarin, Shiv K.
Schmidt, Reinhold E.
Meyer-Olson, Dirk
SpringerLink (Online service)

Other Objects (12)

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Increased CD56bright NK cells in HIV-HCV co-infection and HCV mono-infection are associated with distinctive alterations of their phenotype

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

HIV-HCV Co-infection Among Blood Donors

Characterization of NK cell immunity in chronic HCV infection

HCV co-infection in HIV positive population in British Columbia, Canada

Assessment of human cytomegalovirus co-infection in Egyptian chronic HCV patients

HCV co-infection is related to acute ischemic severity and outcome

Hepatitis C virus (HCV) infection and re-infection among HCV- and HIV/HCV-infected injection drug users

HCV monoinfection and HIV/HCV coinfection enhance T-cell immune senescence in injecting drug users early during infection

HCV-specific T cell responses during and after chronic HCV infection

Managing HCV infection: present and future

Spontaneous HCV clearance in a patient with HIV infection and a concurrent, never treated, evolutive HCV hepatitis, after over twenty years of chronic co-infection

HIV/HCV co-infection and associated risk factors among injecting drug users in Dar es Salaam, Tanzania: potential for HCV elimination

Co-infection with hepatitis C virus (HCV) in Estonian intravenous drug users HIV epidemic

Related objects

Reset password